S Srinivasan is not a usual entrepreneur. You can call him an activist entrepreneur. Srinivasan runs a pharma company and at the same time, raises his voice against industry practices he deems are harmful for customers.
The recent ban on 329 fixed-dose combination drugs by the government citing lack of therapeutic justification, came as a vindication for efforts by him and the All India Drug Action Network, to promote rational use of medicines in the country.
Srinivasan and his team at AIDAN have been working as a pressure group to bring curtains down on hundreds of irrational FDCs that have no scientific basis, and only serve the commercial interests of pharma companies and a section of doctors. This they have done through advocacy, and since 2003, through legal methods as a petitioner in the Supreme Court.
An FDC is a cocktail of two or more active drug ingredients in a medicine.